Triatomic Capital
Signal active
Investment Firm
Overview
Deep tech. Health tech. New economy. AI. Helping great entrepreneurs build 'century-defining' technologies & businesses.
Highlights
Founded
2022
Industry
Employees
11-50
Investment
8
Lead Investment
4
Exits
1
Stages
Early Stage Venture, Seed
Investor Type
Private Equity Firm, Venture Capital
Location
New York, New York, United States, North America
Contact Information
Social
Profile Resume
Triatomic Capital, established in 2022 and headquartered in New York, New York, United States, North America., specializes in Early Stage Venture, Seed investments across Biotechnology, Life Science, Health Care, Financial Services, Venture Capital, Finance, Angel Investment, Pet, Biopharma, Therapeutics. The organization boasts a portfolio of 8 investments, with an average round size of $80.9M and 1 successful exits. Their recent investments include Elegen, Andreessen Horowitz, 8VC, Digitalis Ventures, AME Cloud Ventures. The highest investment round they participated in was $63.2B. Among their most notable exits are Elegen and Andreessen Horowitz. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
Triatomic Capital has made 8 investments. Their most recent investment was on May 14, 2024, when Elegen raised $35.0M.
Triatomic Capital has made 1 diversity investments. Their most recent diversity investment was on Oct 26, 2023, when Betteromics raised $20.0M.
investments
8
Diversity investments
1
Lead investments
4
Number of exits
1
Investments
8
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Sep 12, 2023 | Lyten | Manufacturing | 200.0M |
| Oct 26, 2023 | Betteromics | Software | 20.0M |
| Nov 01, 2023 | Toposware | Information Technology | 5.0M |
| May 14, 2024 | Elegen | Biotechnology | 35.0M |
Exits
1
Funding Timeline
Funding rounds
8
Investors
0
Funds
1
Funding Rounds
8
Triatomic Capital has raised 8 rounds. Their latest funding was raised on May 14, 2024 from a Series B - Elegen round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Sep 12, 2023 | Series B - Lyten | - | 200.0M | - |
| Oct 26, 2023 | Series A - Betteromics | - | 20.0M | - |
| Nov 01, 2023 | Seed Round - Toposware | - | 5.0M | - |
| May 14, 2024 | Series B - Elegen | - | 35.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
N/A
Recent Activity
There is no recent news or activity for this profile.